Palmitelaidic acid-d13
Product Specifications
UNSPSC Description
Palmitelaidic acid-d13 is the deuterium labeled Palmitelaidic Acid. Palmitelaidic Acid (9-trans-Hexadecenoic acid) is the trans isomer of palmitoleic acid. Palmitoleic acid is one of the most abundant fatty acids in serum and tissue.
Target Antigen
AMPK; Glucokinase; Isotope-Labeled Compounds; PPAR
Type
Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage;Epigenetics;Metabolic Enzyme/Protease;Others;PI3K/Akt/mTOR;Vitamin D Related/Nuclear Receptor
Field of Research
Metabolic Disease
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[2H]C([2H])(C([2H])(C([2H])(C([2H])(C([2H])(C([2H])(/C=C/CCCCCCCC(O)=O)[2H])[2H])[2H])[2H])[2H])[2H]
Molecular Weight
267.49
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Frigolet ME, et al. The Role of the Novel Lipokine Palmitoleic Acid in Health and Disease.|[3]de Souza CO, et al. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation. J Cell Physiol. 2016 Dec 7. doi: 10.1002/jcp.25715.|[4]Yang ZH, et al. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis. 2011 Jul 21;10:120.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Clinical Information
No Development Reported
CAS Number
2692623-91-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
14062121 3 x 1.0μg DNA
C19orf35 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details 
